Search tips
Search criteria 


Logo of westjmedLink to Publisher's site
West J Med. 1994 November; 161(5): 483–486.
PMCID: PMC1022676

Prenatal substance use in a Western urban community.


To assess the extent of prenatal substance use in a predominantly white population in an urban area of the western United States and to develop a risk profile for this population, a cross-sectional prevalence study was done. Prenatal clinics (10 public and 10 private) anonymously recorded demographic information about and collected aliquots of routinely obtained urine specimens from women during prenatal visits. Urine specimens were screened by enzyme immunoassay for amphetamines, marijuana, cocaine, opiates, and ethanol. Of the 935 women screened, 92 (9.8%) had urine specimens positive for one or more of these substances. Urine screens were positive in 56 (10.0%) of 562 women attending private clinics and 36 (9.6%) of 373 women attending public clinics. Only 7 of the 935 women (0.7%) had screens positive for cocaine. Ethanol was the most frequently detected substance in the private clinic group (6.4%), whereas marijuana was most common among women attending public clinics (5.1%). Although substance use in this group of pregnant women occurs at a lower rate and a different pattern from those found in other more densely populated areas, the rate is high enough to be of concern to all prenatal care professionals, who should incorporate substance use history taking and selective urine drug screening into their routine prenatal practices.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (746K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Buchi KF, Varner MW, Chase RA. The prevalence of substance abuse among pregnant women in Utah. Obstet Gynecol. 1993 Feb;81(2):239–242. [PubMed]
  • Hawks RL. Analytical methodology. NIDA Res Monogr. 1986;73:30–42. [PubMed]
  • Allen LV, Jr, Stiles ML. Specificity of the EMIT drug abuse urine assay methods. Clin Toxicol. 1981 Sep;18(9):1043–1065. [PubMed]
  • Gillogley KM, Evans AT, Hansen RL, Samuels SJ, Batra KK. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1535–1542. [PubMed]
  • Matera C, Warren WB, Moomjy M, Fink DJ, Fox HE. Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol. 1990 Sep;163(3):797–801. [PubMed]
  • Sloan LB, Gay JW, Snyder SW, Bales WR. Substance abuse during pregnancy in a rural population. Obstet Gynecol. 1992 Feb;79(2):245–248. [PubMed]
  • George SK, Price J, Hauth JC, Barnette DM, Preston P. Drug abuse screening of childbearing-age women in Alabama public health clinics. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 1):924–927. [PubMed]
  • Chasnoff IJ, Landress HJ, Barrett ME. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med. 1990 Apr 26;322(17):1202–1206. [PubMed]
  • Colmorgen GH, Johnson C, Zazzarino MA, Durinzi K. Routine urine drug screening at the first prenatal visit. Am J Obstet Gynecol. 1992 Feb;166(2):588–590. [PubMed]
  • Burke MS, Roth D. Anonymous cocaine screening in a private obstetric population. Obstet Gynecol. 1993 Mar;81(3):354–356. [PubMed]

Articles from The Western Journal of Medicine are provided here courtesy of BMJ Publishing Group